An Efficacy and Safety Study of Beloranib in Obese Subjects With Type 2 Diabetes Mellitus

NCT02324491 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

152

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision to analyze available safety and efficacy data

Conditions

Obesity
Type 2 Diabetes

Interventions

DRUG: ZGN-440 for Injectable Suspension
DRUG: ZGN-440 Placebo for Injectable Suspension

Sponsor

Zafgen, Inc.